Trials of thrombolysis in acute ischemic stroke: Does the choice of primary outcome measure really matter?

Stroke

Volumn 31, Issue 5, 2000, Pages 1133-1135

  Wardlaw, J M ^a   Sandercock, P A G ^a   Warlow, C P ^a   Lindley, R I ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acute; Cerebral infarction; Meta analysis; Stroke; Thrombolytic therapy; Treatment outcome

Indexed keywords

ALTEPLASE; HEPARIN;

ARTICLE; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034099961     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.5.1133     Document Type: Article

References (11)

1. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group: tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Rankin J. Cerebral vascular accidents in people over the age of 60. II: prognosis. Scot Med J. 1957;2:200-215.
3. del Zoppo GJ, Hisjashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. and the PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
4. Clark WM, Albers GW, for the ATLANTIS Stroke Study Investigators. The ATLANTIS rt-PA (Alteplase) Acute Stroke Trial: final results. Stroke. 1999;30:234. Abstract 13.
5. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolytic therapy in acute ischaemic stroke: part I. thrombolysis versus control. In: Warlow C. Van Gijn J, Sandercock P. eds Stroke Module of The Cochrane Database of Systemic Reviews [updated October 1, 1999]. Available in The Cochrane Library [database on disk and CD-ROM]. The Cochrane Collaboration: 1999, issue 4 Oxford, UK: Update Software.
6. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P, for the Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-1251.
7. European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA. 1995;274:1017-1025.
8. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F, for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999;282:2003-2011.
9. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995;346:1509-1514.
10. Counsell CE, Clarke MJ, Slattery J, Sandercock PAG. The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis? BMJ. 1994;309:1677-1681.
11. Horowitz SH. Thrombolytic therapy in acute stroke: neurologists, get off your hands! Arch Neurol. 1998;55:155-157.